Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Growth Projections For The Gene Therapy Clinical Trial Services Market Size During 2025–2029?
The gene therapy clinical trial services market size has witnessed rapid expansion in recent years. It is projected to increase from $1.53 billion in 2024 to $1.82 billion in 2025, at a compound annual growth rate (CAGR) of 19.6%. The historical growth of this market can be attributed to several factors: increasing research and development investment, the rising prevalence of rare genetic disorders, a growing adoption of precision medicine approaches, enhanced regulatory support facilitated by accelerated approval pathways, and an increasing number of gene therapy candidates.
The gene therapy clinical trial services market size is expected to experience substantial expansion in the coming years. It is projected to reach $3.69 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 19.2%. This growth during the forecast period can be attributed to increasing technological advancements in gene-editing tools, a rising number of clinical trials, heightened demand for personalized treatment, growing investment in manufacturing infrastructure for cell and gene therapies, and enhanced patient recruitment efforts. Key trends anticipated in the forecast period include improvements in gene-editing technologies, progress in vector manufacturing capabilities, advancements in patient recruitment strategies, the incorporation of real-world evidence, and the adoption of the decentralized trial model.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27292&type=smp
What Are The Top Growth Drivers Impacting The Gene Therapy Clinical Trial Services Market Outlook?
The gene therapy clinical trial services market is projected to expand moving forward due to the escalating demand for personalized medicine. This approach, personalized medicine, tailors medical treatment to individual characteristics like genetic, biomarker, and lifestyle factors. The rising demand for personalized medicine is fueled by advancements in genomics and biotechnology, which enable more precise targeting of therapies. Gene therapy clinical trial services support personalized medicine by analyzing patient-specific genetic profiles and customizing treatments accordingly, utilizing biomarker analysis and companion diagnostics to optimize therapy for each individual while enhancing safety and effectiveness. For instance, in February 2024, the Personalized Medicine Coalition, a US-based hospital and health care organization, reported that in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Therefore, the growing demand for personalized medicine is driving the growth of the gene therapy clinical trial services market.
What Are The Emerging Segments Gaining Attention In The Gene Therapy Clinical Trial Services Market?
The gene therapy clinical trial services market covered in this report is segmented
1) By Type: Clinical Trial Design And Planning, Supply And Logistics Services, Regulatory Services, Data Management And Biostatistics, Site Management And Monitoring, Other Types
2) By Application: Oncology, Hematology, Endocrine or Metabolic Disorders, Musculoskeletal Diseases, Cardiovascular Diseases, Neurology Disorders, Infectious Diseases, Ophthalmology, Immunology, Other Applications
3) By End-User: Pharmaceutical Companies, Biotechnology Companies, Academic Institutions, Government Research Institutes, Contract Research Organizations (CROs)
Subsegments:
1) By Clinical Trial Design And Planning: Protocol Development, Feasibility Studies, Patient Recruitment Strategy Design
2) By Supply And Logistics Services: Cold Chain Management, Investigational Product Packaging And Labeling, Controlled-Temperature Storage
3) By Regulatory Services: Regulatory Consulting And Strategy, Ethics Committee Submissions, Regulatory Compliance Monitoring
4) By Data Management And Biostatistics: Clinical Data Capture And Database Design, Data Validation And Quality Control, Statistical Analysis And Modeling
5) By Site Management And Monitoring: Site Selection And Qualification, Investigator Training And Support, On-Site Monitoring Visits
6) By Other Types: Pharmacovigilance And Safety Reporting, Quality Assurance And Auditing, Patient Engagement And Retention
What Trends Are Expected To Drive The Gene Therapy Clinical Trial Services Market?
Companies operating in the gene therapy clinical trial services market are concentrating on developing innovative solutions like the long-term follow-up (LTFU) model for cell and gene therapy (CGT) trials. This effort aims to accelerate the entire trial process while upholding regulatory compliance and safety standards. An LTFU model for cell and gene therapy (CGT) trials is a structured framework designed to monitor patients for an extended period, often up to 15 years after they receive a CGT treatment. For example, in May 2025, Medable Inc., a US-based SaaS company, introduced a digital-first Long-Term Follow-Up (LTFU) model specifically tailored for cell and gene therapy (CGT) trials. This model supports cell and gene therapy trials by decreasing the burden on patients and sites while maintaining scientific rigor during the FDA-required 15-year monitoring period. It also improves patient access, retention, and data continuity via remote and hybrid follow-up methods, thereby enhancing the monitoring of long-term safety and efficacy.
Who Are The Prominent Global Companies Shaping The Gene Therapy Clinical Trial Services Market?
Major companies operating in the gene therapy clinical trial services market are Thermo Fisher Scientific Inc., Sharp Services LLC, Labcorp, Pharmaceutical Product Development LLC, ICON plc, Syneos Health Inc., WuXi AppTec, Franklin Biolabs, Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Medpace Holdings Inc., Precision Medicine Group LLC, Worldwide Clinical Trials, IQVIA Holdings Inc., TFS HealthScience, Poseida Therapeutics Inc., Veristat LLC, Genprex Inc., Novotech Health Holdings Pte Limited, bluebird bio Inc.
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Gene Therapy Clinical Trial Services Market?
North America was the largest region in the gene therapy clinical trial services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene therapy clinical trial services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Gene Therapy Clinical Trial Services Market Report:
https://www.thebusinessresearchcompany.com/customise?id=27292&type=smp
Browse Through More Reports Similar to the Global Gene Therapy Clinical Trial Services Market 2025, By The Business Research Company
Takaful Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/takaful-global-market-report
Nitrobenzene Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/nitrobenzene-global-market-report
Triazole Fungicides Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/triazole-fungicides-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model